SynBiotic SE
XETRA SBX.DE
SynBiotic SE Net Income for the year ending December 31, 2023: USD -11.73 M
SynBiotic SE Net Income is USD -11.73 M for the year ending December 31, 2023, a 54.99% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
-
SynBiotic SE Net Income for the year ending December 31, 2022 was USD -26.07 M, a -75.20% change year over year.
-
SynBiotic SE Net Income for the year ending December 31, 2021 was USD -14.88 M, a -1,283.39% change year over year.
-
SynBiotic SE Net Income for the year ending December 31, 2020 was USD -1.08 M, a -7,036.21% change year over year.
-
SynBiotic SE Net Income for the year ending December 31, 2019 was USD -15.07 K, a -1,501.94% change year over year.
Key data
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Net Income Margin |
|---|
Market news
Loading...
XETRA: SBX.DE
| CEO | Mr. Daniel Kruse |
| IPO Date | Jan. 7, 2021 |
| Location | Germany |
| Headquarters | Innere Wiener Str. 14 |
| Employees | 55 |
| Sector | Health Care |
| Industries | |
Description
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email